Cargando…

Treatment of Fabry Nephropathy: A Literature Review

Fabry disease is an X-linked inherited lysosomal storage disorder with a deficiency of α-galactosidase A activity, which results in the intracellular accumulation of globotriaosylceramide (Gb3) and related glycosphingolipids in various organs. Fabry nephropathy is one of the major complications of F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimohata, Homare, Yamashita, Marina, Yamada, Kota, Hirayama, Kouichi, Kobayashi, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456687/ https://www.ncbi.nlm.nih.gov/pubmed/37629768 http://dx.doi.org/10.3390/medicina59081478

Ejemplares similares

A Renal Variant of Fabry Disease Diagnosed by the Presence of Urinary Mulberry Cells
por: Shimohata, Homare, et al.
Publicado: (2016)

Staphylococcus aureus Infection-Related Glomerulonephritis with Dominant IgA Deposition
por: Takayasu, Mamiko, et al.
Publicado: (2022)

Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature
por: Miyamoto, Yasunori, et al.
Publicado: (2019)

Non-hereditary multiple renal cysts in unilateral kidney
por: Miyamoto, Yasunori, et al.
Publicado: (2011)

Serum 20S proteasome levels are associated with disease activity in MPO-ANCA-associated microscopic polyangiitis
por: Maruyama, Hiroshi, et al.
Publicado: (2020)

An Adult Patient with Alagille Syndrome Showing Mainly Renal Failure and Vascular Abnormality without Liver Manifestation
por: Shimohata, Homare, et al.
Publicado: (2020)

Retention of acetylcarnitine in chronic kidney disease causes insulin resistance in skeletal muscle
por: Miyamoto, Yasunori, et al.
Publicado: (2016)

A Case of Proliferative Glomerulonephritis with Monoclonal IgG Deposits That Showed Predominantly Membranous Features
por: Shimohata, Homare, et al.
Publicado: (2017)

Fabry nephropathy: a review – how can we optimize the management of Fabry nephropathy?
por: Waldek, Stephen, et al.
Publicado: (2014)

Biomarkers of Fabry Nephropathy: Review and Future Perspective
por: Levstek, Tina, et al.
Publicado: (2020)

IgA nephropathy with mimicking Fabry disease: A case report and literature review
por: Sun, Liping, et al.
Publicado: (2022)

Diagnosing Fabry nephropathy: the challenge of multiple kidney disease
por: Esposito, Pasquale, et al.
Publicado: (2023)

The Immunobiological Agents for Treatment of Antiglomerular Basement Membrane Disease
por: Yamashita, Marina, et al.
Publicado: (2023)

Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
por: Fervenza, Fernando C, et al.
Publicado: (2008)

Fabry nephropathy: 5 years of enzyme replacement therapy—a short review
por: Barbey, Frédéric, et al.
Publicado: (2008)

Coincidental finding of Fabry’s disease in a patient with IgA nephropathy
por: Kakita, Tomoko, et al.
Publicado: (2010)

The coincidence of IgA nephropathy and Fabry disease
por: Maixnerová, Dita, et al.
Publicado: (2013)

A questionnaire survey on the diagnosis and treatment of Fabry nephropathy in clinical practice
por: Choi, Soo Jeong, et al.
Publicado: (2023)

Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy
por: Fall, Brent, et al.
Publicado: (2016)

Quality of life in patients with Fabry disease: a systematic review of the literature
por: Arends, Maarten, et al.
Publicado: (2015)

Stroke and Fabry Disease: A Review of Literature
por: Mishra, Vinayak, et al.
Publicado: (2020)

Kidney Transplant in Fabry Disease: A Revision of the Literature
por: Capelli, Irene, et al.
Publicado: (2020)

Fabry nephropathy before and after enzyme replacement therapy: important role of renal biopsy in patients with Fabry disease
por: Kim, Il Young, et al.
Publicado: (2021)

Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy
por: Braun, Fabian, et al.
Publicado: (2023)

Pathologic findings of Fabry nephropathy: the pivotal role of kidney biopsy
por: Shin, Jung-ho, et al.
Publicado: (2021)

Fabry's Disease: Case Series and Review of Literature
por: Wani, Muzaffar Maqsood, et al.
Publicado: (2016)

Concurrent fabry disease and immunoglobulin a nephropathy: a case report
por: Zhou, Li-Na, et al.
Publicado: (2023)

Is there a pathogenic association between Fabry’s disease and IgA nephropathy?
por: Fujinaga, Shuichiro, et al.
Publicado: (2013)

Coexistence of Fabry disease with IgM nephropathy: A case report
por: Wu, Huizhen, et al.
Publicado: (2019)

High-Risk Screening for Fabry Disease: A Nationwide Study in Japan and Literature Review
por: Sawada, Takaaki, et al.
Publicado: (2021)

Developments in the treatment of Fabry disease
por: van der Veen, Sanne J., et al.
Publicado: (2020)

Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy
por: Levstek, Tina, et al.
Publicado: (2021)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Atherosclerosis in Fabry Disease—A Contemporary Review
por: Roy, Ashwin, et al.
Publicado: (2021)

Fabry Disease and the Heart: A Comprehensive Review
por: Azevedo, Olga, et al.
Publicado: (2021)

Fabry Disease: The Current Treatment Landscape
por: Lenders, Malte, et al.
Publicado: (2021)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Direct Correlation between Age at Diagnosis and Severity of Nephropathy in Fabry Disease Patients
por: Jaurretche, Sebastián P. A., et al.
Publicado: (2019)

Treatment of Fabry Disease: Established and Emerging Therapies
por: Umer, Muhammad, et al.
Publicado: (2023)

Fabry Cardiomyopathy: Current Treatment and Future Options
por: Vardarli, Irfan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_siqmjnc0shujes2lljctq3sq3p